CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users
NCT ID: NCT07297524
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
25 participants
INTERVENTIONAL
2025-12-22
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will use the Multimodal Acoustic Therapy (MAT) mobile application at home for 12 weeks to improve music and speech perception.
Participants will visit the site twice (baseline and post-intervention), while all other evaluations, including follow-up, will be conducted online.
The first on-site visit is mainly to on-board participants and to train them for accurate use of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Device: Auditory rehabilitation application Application: Wowfit
Mobile Auditory Rehabilitation
Mobile Application for Auditory Rehabilitation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile Auditory Rehabilitation
Mobile Application for Auditory Rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Korean patients aged 10 to 19 years
* Capable of using a smartphone
* Scored ≤80% on MCI pre-assessment
* Voluntarily agreed to participate in this study
Exclusion Criteria
* Has intellectual disability, congenital malformation, or other neurological disorders affecting language or cognitive abilities
* Has diagnosed emotional disorders such as depression or anxiety
* Primarily uses sign language for daily communication
* Has undergone cochlear implant revision surgery
* Has prior experience with the investigational auditory rehabilitation application used in this study
10 Years
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BELL Therapeutics Inc.
INDUSTRY
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang-Yeon Lee
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sang-Yeon Lee, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-2404-090-1531
Identifier Type: -
Identifier Source: org_study_id